These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8430887)

  • 61. Cholecystokinin-induced variations in hypothalamic serotonergic system of the "cafeteria" rat.
    Orosco M; Gourch A; Cohen Y; Jacquot C
    Brain Res Bull; 1990 Dec; 25(6):949-52. PubMed ID: 1705163
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of the 5-HT3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein.
    Herberg LJ; De Belleroche JS; Rose IC; Montgomery AM
    Neurosci Lett; 1992 Jun; 140(1):16-8. PubMed ID: 1407694
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatic-portal infusion reduces the satiating potency of CCK-8.
    Greenberg D; Smith GP
    Physiol Behav; 1988; 44(4-5):535-8. PubMed ID: 3237843
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the satiating potencies of cholecystokinin-33 and cholecystokinin-8.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1993 May; 45(1):85-7. PubMed ID: 8516377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Centrally active 5-HT receptor agonists and antagonists.
    Middlemiss DN; Tricklebank MD
    Neurosci Biobehav Rev; 1992; 16(1):75-82. PubMed ID: 1553108
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of serotonergic mechanisms in leptin-induced suppression of milk intake in mice.
    Yamada J; Sugimoto Y; Hirose H; Kajiwara Y
    Neurosci Lett; 2003 Sep; 348(3):195-7. PubMed ID: 12932826
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Obesity induced by unspecific early postnatal overfeeding in male and female rats: hypophagic effect of CCK-8S.
    Voits M; Förster S; Rödel S; Voigt JP; Plagemann A; Fink H
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):374-8. PubMed ID: 8878070
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
    O'Harte FP; Mooney MH; Kelly CM; Flatt PR
    Diabetes; 1998 Oct; 47(10):1619-24. PubMed ID: 9753301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of serotonin synthesis attenuates inhibition of ingestive behavior by CCK-8.
    Esfahani N; Bednar I; Qureshi GA; Södersten P
    Pharmacol Biochem Behav; 1995 May; 51(1):9-12. PubMed ID: 7617739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla.
    Daughters RS; Hofbauer RD; Grossman AW; Marshall AM; Brown EM; Hartman BK; Faris PL
    Peptides; 2001 Aug; 22(8):1331-8. PubMed ID: 11457529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reflex circulatory collapse following intrapulmonary entrapment of activated platelets: mediation via 5-HT3 receptor stimulation.
    Leaños OL; Hong E; Amezcua JL
    Br J Pharmacol; 1995 Oct; 116(3):2048-52. PubMed ID: 8640344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats.
    Fadda F; Garau B; Marchei F; Colombo G; Gessa GL
    Alcohol Alcohol; 1991; 26(2):107-10. PubMed ID: 1878073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stereoselective interaction of mianserin with 5-HT3 receptors.
    Wood MD; Thomas DR; Watkins CJ; Newberry NR
    J Pharm Pharmacol; 1993 Aug; 45(8):711-4. PubMed ID: 7901368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The 5-HT2 receptor antagonist reduces immobility of mice treated with the atypical antidepressant mianserin in the forced swimming test.
    Sugimoto Y; Yamada S; Yamada J
    Biol Pharm Bull; 2002 Nov; 25(11):1479-81. PubMed ID: 12419964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lack of effects of 5-HT3 antagonists on normal and morphine-attenuated sexual behaviours in female and male rats.
    Tanco SA; Watson NV; Gorzalka BB
    Experientia; 1993 Mar; 49(3):238-41. PubMed ID: 8458409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake.
    Savastano DM; Carelle M; Covasa M
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1499-508. PubMed ID: 15718390
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Different temporal effects of serotonergic antagonists on passive avoidance retention.
    Altman HJ; Normile HJ
    Pharmacol Biochem Behav; 1987 Nov; 28(3):353-9. PubMed ID: 3685070
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 5-HT2 receptor antagonists and migraine therapy.
    Mylecharane EJ
    J Neurol; 1991; 238 Suppl 1():S45-52. PubMed ID: 2045831
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effects of 5-HT receptor blockade on memory formation in the chick: possible interactions between beta-adrenergic, and serotonergic systems.
    Stephenson RM; Andrew RJ
    Pharmacol Biochem Behav; 1994 Aug; 48(4):971-5. PubMed ID: 7972303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 5-HT2 and 3 receptor antagonists suppress the response of rat type I slowly adapting mechanoreceptor: an in vitro study.
    He L; Tuckett RP; English KB
    Brain Res; 2003 Apr; 969(1-2):230-6. PubMed ID: 12676383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.